dsdsa

product

Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We aim to find out high quality disfigurement in the generation and provide the most effective services to domestic and abroad clients wholeheartedly for Lanreotide, 61825-94-3, Daclatasvir, If you have any comments about our company or products, please feel free to contact us, your coming mail will be highly appreciated.
Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai Detail:

Product name AZD-9291 mesylate
Synonyms N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1)
CAS No. 1421373-66-1
Appearance White to light yellow solid powder
Molecular Formula C28H33N7O2.CH4O3S
Molecular Weight 595.71
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

AZD-9291 mesylate CAS:1421373-66-1

Items

Standards

Results

Appearance

White to light yellow solid powder

Light yellow solid powder

Identification

By IR

Complies

By HPLC

Complies

Solubility

Soluble in Dimethylsulfoxide,slightly soluble in Ethanol and Acetonitrile,with pH dependent aqueous solubility

Complies

Water Content(KF)

≤ 1.00%

0.42%

Residue on Ignition

≤ 0.10%

0.05%

Heavy Metal

≤ 20ppm

Complies

Mesylate

15.20%~18.20%

15.90%

Residual Solvents

Acetonitrile: ≤410ppm

ND

Acetone: ≤5000ppm

ND

Tetrahydrofuran: ≤720ppm

ND

Related Substances

Maximum single impurity: ≤0.20%

0.17%

Total impurities: ≤1.00%

0.25%

Particle Size

D90: ≤100μm

57.97%

Assay

(HPLC basis on drying)

98.00%~102.00%

99.80%

Reference Standard

In-house Standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures

Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures

Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai detail pictures


Related Product Guide:

We constantly continually give you essentially the most conscientious client provider, plus the widest variety of designs and styles with finest materials. These initiatives include the availability of customized designs with speed and dispatch for Good Quality Anti-Tumor Drugs - High Purity Pharmaceutical Grade 1421373-66-1 Mesylate-AZD9291 for Cancer Treatment – Yibai , The product will supply to all over the world, such as: Austria, Singapore, Norway, We strongly believe that technology and service is our base today and quality will create our reliable walls of future. Only we've got better and better quality , could we achieve our customers and ourselves, too. Welcome customers all over the word to contact us for getting further business and reliable relationships. We have been always here working for your demands whenever you require.
  • The company has rich resources, advanced machinery, experienced workers and excellent services, hope you keep improving and perfecting your products and service, wish you better!
    5 Stars By Deirdre from Auckland - 2018.05.13 17:00
    The manufacturer gave us a big discount under the premise of ensuring the quality of products, thank you very much, we will select this company again.
    5 Stars By Sharon from Cancun - 2017.11.29 11:09
    Write your message here and send it to us